+91 780-304-0404

Indian Infertility Diagnosis and Treatment Market

Indian Infertility Diagnosis and Treatment Market Size, Share & Trends Analysis Report, by Female Infertility Diagnosis (Ovulation Testing, Hysterosalpingography, Hysteroscopy, Imaging Testing, Ovarian Reserve Testing, Hormonal Level Testing, Genetic Testing, and Others), by Male Infertility Diagnosis (Semen Analysis, Genetic Testing, Testicular Biopsy, Hormone Testing, and Others) and by Infertility Treatment (Drugs And Medicine, Surgical, Assisted Reproductive Technology (ART), and Others)Forecast Period (2022-2028)
    Update Available - Forecast 2024-2030   

Published: Jul 2019 | Report Code: OMR2017108 | Category : Biotechnology | Delivery Format: /
Indian infertility diagnosis and treatment market is anticipated to grow at a significant CAGR of 12.5% during the forecast period. The major factor that is augmenting the growth of the market includes the rising alcohol and cigarette consumption in India. Alcohol consumption in India is one of the major factors responsible for infertility in the country. Alcohol consumption in India has risen by 55.0% during the last two decades. Furthermore, the young generation age less than 20 are getting initiated to alcohol much earlier, whereas more women are indulging in binge and hazardous drinking. According to the National Family Health Survey-4, 29.2% of men and 1.2% of women consume alcohol. Alcohol consumption among females can cause irregular periods and irregular ovulation which reduce the chances of conception. Therefore the increasing alcohol consumption is estimated to augment the demand for infertility treatment in India.

Impact of COVID-19 Pandemic on Indian Infertility Diagnosis and Treatment Market

During the COVID-19 pandemic, a drastic drop was observed in the number of people undergoing IVF cycles. The infertility diagnostic procedure, whether fresh or frozen and elective surgeries were canceled due to the COVID-19 pandemic. The spread of COVID-19 has not only impacted fertility clinics owing to the cancellation of IVF treatments but has also affected fertility decisions among couples who were opting for IVF treatment before the pandemic.

Segmental Outlook 

The Indian infertility diagnosis and treatment market is segmented based on the female infertility diagnosis, male infertility diagnosis, and infertility treatment. Based on the Female Infertility Diagnosis, the market is segmented into ovulation testing, hysterosalpingography, hysteroscopy, imaging testing, ovarian reserve testing, hormonal level testing, genetic testing, and others. Based on the male infertility diagnosis, the market is sub-segmented into semen analysis, genetic testing, testicular biopsy, hormone testing, and others.Based on the infertility treatment the market is sub-segmented into the drugs and medicine, surgical, assisted reproductive technology (ART), and others. The above-mentioned segments can be customized as per the requirements.Among this semen analysis segment is expected to cater a significant share in the Indian infertility diagnosis and treatment market due to its higher sensitivity that assists to detect the condition among men suffering from the problem of males.

Indian Infertility Diagnosis and Treatment Market Share by Infertility Treatment, 2021 (%)
 
Indian Infertility Diagnosis and Treatment Market Share by Infertility Treatment

The Assisted Reproductive Technology (ART) Segment is Expected to Hold the Prominent Share in the Indian Infertility Diagnosis and Treatment Market

The assisted reproductive technology (ART) segment is expected to hold a prominent share in the Indian infertility diagnosis and treatment market due to the rapid adoption of assisted reproductive technologies including in-vitro fertilization (IVF), intrauterine insemination, intrafallopian transfer, intracytoplasmic sperm injection (ICSI), and frozen embryo replacement. Furthermore, the advancement in research & development activities and the growing number of IVF clinics have further boosted the assisted reproductive technology (ART) segment in the Indian infertility diagnosis and treatment market. For Instance, in December 2021, Mira IVF, the first international level fertility center Nova IVF Fertility was launched in Indore. It is provided with state-of-the-art equipment and technology. 

Market Players Outlook

The major companies serving the Indian infertility diagnosis and treatment market include Cipla Inc., GlaxoSmithKline plc., Abbott India Ltd., Cadila Healthcare Ltd, Crysta IVF, Dr. D Pharma, Maksun Biotech Pvt. Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2020, Artemis Hospital, Gurugram celebrated 10 years of greatness in IVF (In vitro fertilization) by establishing a specialized infertility program and awareness campaign. Technological advancements have come as a boon for couples facing problems in conceiving and IVF is one of them. On this occasion, the hospital organized free OPD consultations for the couple attending the IVF camp.

The Report Covers

  • Market value data analysis of 2021 and forecast to 2028.
  • Annualized market revenues ($ million) for each market segment.
  • Key companies operating in the Indian infertility diagnosis and treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of marketentry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook

• Impact of COVID-19 on the Indian Infertility Diagnosis and Treatment Market

• Recovery Scenario of Indian Infertility Diagnosis and Treatment Market

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

3. Competitive Landscape

3.1. Cipla Inc.

3.1.1. Overview

3.1.2. Financial Analysis 

3.1.3. SWOT Analysis

3.1.4. Recent Developments

3.2. GlaxoSmithKline plc.

3.2.1. Overview

3.2.2. Financial Analysis 

3.2.3. SWOT Analysis

3.2.4. Recent Developments

3.3. Abbott India Ltd.

3.3.1. Overview

3.3.2. Financial Analysis 

3.3.3. SWOT Analysis

3.3.4. Recent Developments

3.4. Key Strategy Analysis

3.5. Impact of Covid-19 on Key Players

4. Market Segmentation

4.1. Indian Infertility Diagnosis and Treatment Market by Female Infertility Diagnosis

4.1.1. Ovulation Testing 

4.1.2. Hysterosalpingography 

4.1.3. Hysteroscopy 

4.1.4. Imaging Testing 

4.1.5. Ovarian Reserve Testing 

4.1.6. Hormonal Level Testing 

4.1.7. Enetic Testing 

4.1.8. Others

4.2. Indian Infertility Diagnosis and Treatment Market Market by Male Infertility Diagnosis

4.2.1. Semen Analysis

4.2.2. Genetic Testing

4.2.3. Testicular Biopsy

4.2.4. Hormone Testing

4.2.5. Others

4.3. Indian Infertility Diagnosis and Treatment Market Market by Infertility Treatment

4.3.1. Drugs And Medicine

4.3.2. Surgical

4.3.3. Assisted Reproductive Technology (ART)

4.3.4. Others

5. Company Profiles 

5.1. Adorefem

5.2. Biofield Pharma Pvt. Ltd.

5.3. Cadila Healthcare Ltd.

5.4. Crysta IVF

5.5. Dr. D Pharma

5.6. Maksun Biotech Pvt. Ltd.

5.7. Mestra pharma Pvt Ltd.

5.8. Moolchand Healthcare Pvt Ltd.

5.9. Nova IVF Fertility Pvt Ltd.

5.10. Novartis AG

5.11. Pax Healthcare

5.12. Pfizer Ltd, India

5.13. Sun Pharmaceutical Industries Ltd.

5.14. Zauba Technologies & Data Services Pvt. Ltd.

1. INDIAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY FEMALE INFERTILITY DIAGNOSIS, 2021-2028 ($ MILLION)

2. INDIAN INFERTILITY DIAGNOSIS AND TREATMENT MARKETRESEARCH AND ANALYSIS BY MALE INFERTILITY DIAGNOSIS, 2021-2028 ($ MILLION)

3. INDIAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY INFERTILITY TREATMENT, 2021-2028 ($ MILLION)

1. IMPACT OF COVID-19 ON INDIAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET, 2021-2028 ($ MILLION)

2. IMPACT OF COVID-19 ON INDIAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET BY SEGMENT, 2021-2028 ($ MILLION)

3. RECOVERY OF INDIAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET, 2022-2028 (%)

4. INDIAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY FEMALE INFERTILITY DIAGNOSIS, 2021 VS 2028 (%)

5. INDIAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET MARKET SHARE BY MALE INFERTILITY DIAGNOSIS, 2021 VS 2028 (%)

6. INDIAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET MARKET SHARE BY INFERTILITY TREATMENT, 2021 VS 2028 (%)

Choose License Type
    On Discount

100%
Secured Payment

Why buy from us?
  • Covers more than 15 major industries, which are further segmented into 90+ sectors
  • 65% of our clients are loyal customers
  • 120+ countries are covered in analysis
  • currently servicing 1000+ customers globally
  • 100+ paid data sources mined to research
  • Our expert team will assist you with all research need and customization
  • Our expert research analyst will resolve your every query before and after purchasing the report
Related Reports